Carolyn M. Tastad's most recent trade in Kellogg Co was a trade of 2,119 Common done at an average price of $82.6 . Disclosure was reported to the exchange on May 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kellanova | Carolyn M. Tastad | Director | Grant, award, or other acquisition of securities at price $ 82.61 per share. | 05 May 2025 | 2,119 | 28,664 (0%) | 0% | 82.6 | 175,051 | Common |
| Kellanova | Carolyn M. Tastad | Director | Other type of transaction at price $ 0.00 per share. | 28 Dec 2024 | 914 | 26,545 (0%) | 0% | 0 | Common | |
| Kellanova | Carolyn M. Tastad | Director | Grant, award, or other acquisition of securities at price $ 60.04 per share. | 06 May 2024 | 2,915 | 25,631 (0%) | 0% | 60.0 | 175,017 | Common |
| Kellanova | Carolyn M. Tastad | Director | Other type of transaction at price $ 0.00 per share. | 30 Dec 2023 | 849 | 22,716 (0%) | 0% | 0 | Common | |
| Kellanova | Carolyn M. Tastad | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2023 | 2,180 | 21,866 (0%) | 0% | 0 | Common | |
| Kellanova | Carolyn M. Tastad | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2022 | 647 | 19,686 (0%) | 0% | 0 | Common | |
| Kellanova | Carolyn M. Tastad | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 2,080 | 19,039 (0%) | 0% | 0 | Common | |
| P&G | Carolyn M. Tastad | CEO - Health Care | Sale of securities on an exchange or to another person at price $ 153.51 per share. | 01 Mar 2022 | 3,730 | 28,156 (0%) | 0% | 153.5 | 572,597 | Common Stock |
| P&G | Carolyn M. Tastad | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 38 | 658 | - | - | Restricted Stock Units | |
| Kellanova | Carolyn M. Tastad | Director | Other type of transaction at price $ 0.00 per share. | 01 Jan 2022 | 586 | 16,959 (0%) | 0% | 0 | Common | |
| P&G | Carolyn M. Tastad | CEO - Health Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 148.84 per share. | 06 Dec 2021 | 170 | 31,760 (0%) | 0% | 148.8 | 25,302 | Common Stock |
| P&G | Carolyn M. Tastad | CEO - Health Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2021 | 62 | 818 | - | - | Restricted Stock Units | |
| P&G | Carolyn M. Tastad | CEO - Health Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 150.61 per share. | 06 Dec 2021 | 62 | 31,930 (0%) | 0% | 150.6 | 9,338 | Common Stock |
| P&G | Carolyn M. Tastad | CEO - Health Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 150.61 per share. | 06 Dec 2021 | 62 | 31,992 (0%) | 0% | 150.6 | 9,338 | Common Stock |
| P&G | Carolyn M. Tastad | CEO - Health Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 149.71 per share. | 06 Dec 2021 | 42 | 31,717 (0%) | 0% | 149.7 | 6,288 | Common Stock |
| P&G | Carolyn M. Tastad | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2021 | 39 | 620 | - | - | Restricted Stock Units | |
| P&G | Carolyn M. Tastad | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 62,731 | 62,731 | - | - | Stock Option (Right to Buy) | |
| P&G | Carolyn M. Tastad | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 3,251 | 31,748 (0%) | 0% | 0 | Common Stock | |
| P&G | Carolyn M. Tastad | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 124 | 3,972 | - | - | Series A Preferred Stock | |
| P&G | Carolyn M. Tastad | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2021 | 72,862 | 72,862 | - | - | Stock Option (Right to Buy) | |
| P&G | Carolyn M. Tastad | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2021 | 28,152 | 56,649 (0%) | 0% | 0 | Common Stock | |
| P&G | Carolyn M. Tastad | CEO - Health Care | Sale of securities on an exchange or to another person at price $ 143.90 per share. | 17 Aug 2021 | 15,456 | 28,497 (0%) | 0% | 143.9 | 2,224,118 | Common Stock |
| P&G | Carolyn M. Tastad | CEO - Health Care | Sale of securities on an exchange or to another person at price $ 144.37 per share. | 17 Aug 2021 | 12,696 | 43,953 (0%) | 0% | 144.4 | 1,832,934 | Common Stock |
| P&G | Carolyn M. Tastad | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2021 | 37 | 580 | - | - | Restricted Stock Units | |
| P&G | Carolyn M. Tastad | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 881 | 881 | - | - | Restricted Stock Units | |
| P&G | Carolyn M. Tastad | CEO - Health Care | Sale of securities on an exchange or to another person at price $ 141.77 per share. | 02 Aug 2021 | 7,772 | 28,333 (0%) | 0% | 141.8 | 1,101,836 | Common Stock |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Sale of securities on an exchange or to another person at price $ 138.20 per share. | 26 May 2021 | 3,000 | 36,105 (0%) | 0% | 138.2 | 414,600 | Common Stock |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 38 | 581 | - | - | Restricted Stock Units | |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Sale of securities on an exchange or to another person at price $ 137.27 per share. | 11 May 2021 | 3,513 | 38,935 (0%) | 0% | 137.3 | 482,243 | Common Stock |
| Kellanova | Carolyn M. Tastad | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2021 | 2,273 | 16,373 (0%) | 0% | 0 | Common | |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Sale of securities on an exchange or to another person at price $ 125.77 per share. | 26 Feb 2021 | 6,661 | 43,667 (0%) | 0% | 125.8 | 837,763 | Common Stock |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Sale of securities on an exchange or to another person at price $ 125.77 per share. | 26 Feb 2021 | 1,219 | 42,448 (0%) | 0% | 125.8 | 153,315 | Common Stock |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 37 | 543 | - | - | Restricted Stock Units | |
| Kellanova | Carolyn M. Tastad | Director | Other type of transaction at price $ 0.00 per share. | 02 Jan 2021 | 469 | 14,100 (0%) | 0% | 0 | Common | |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2020 | 700 | 50,259 (0%) | 0% | 0 | Common Stock | |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 137.07 per share. | 15 Dec 2020 | 257 | 50,133 (0%) | 0% | 137.1 | 35,227 | Common Stock |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 67 | 880 | - | - | Restricted Stock Units | |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 137.61 per share. | 15 Dec 2020 | 67 | 50,434 (0%) | 0% | 137.6 | 9,220 | Common Stock |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 137.61 per share. | 15 Dec 2020 | 67 | 50,501 (0%) | 0% | 137.6 | 9,220 | Common Stock |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 137.60 per share. | 15 Dec 2020 | 43 | 50,391 (0%) | 0% | 137.6 | 5,917 | Common Stock |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 33 | 506 | - | - | Restricted Stock Units | |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2020 | 30,371 | 0 | - | - | Stock Option (Right to Buy) | |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Sale of securities on an exchange or to another person at price $ 142.94 per share. | 27 Oct 2020 | 30,371 | 50,959 (0%) | 0% | 142.9 | 4,341,158 | Common Stock |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.45 per share. | 27 Oct 2020 | 30,371 | 81,330 (0%) | 0% | 69.5 | 2,109,266 | Common Stock |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Sale of securities on an exchange or to another person at price $ 142.94 per share. | 27 Oct 2020 | 21,496 | 50,959 (0%) | 0% | 142.9 | 3,072,587 | Common Stock |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2020 | 21,496 | 0 | - | - | Stock Option (Right to Buy) | |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.87 per share. | 27 Oct 2020 | 21,496 | 72,455 (0%) | 0% | 83.9 | 1,802,870 | Common Stock |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2020 | 134 | 3,848 | - | - | Series A Preferred Stock | |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 58,438 | 58,438 | - | - | Stock Option (Right to Buy) | |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 2,969 | 50,959 (0%) | 0% | 0 | Common Stock | |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 75,947 | 75,947 | - | - | Stock Option (Right to Buy) | |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2020 | 35,874 | 83,864 (0%) | 0% | 0 | Common Stock | |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Sale of securities on an exchange or to another person at price $ 136.00 per share. | 18 Aug 2020 | 19,043 | 47,990 (0%) | 0% | 136 | 2,589,848 | Common Stock |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Sale of securities on an exchange or to another person at price $ 136.53 per share. | 18 Aug 2020 | 16,831 | 67,033 (0%) | 0% | 136.5 | 2,297,883 | Common Stock |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2020 | 29 | 472 | - | - | Restricted Stock Units | |
| P&G | Carolyn M. Tastad | Group Pres-Chief Sales Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2020 | 948 | 948 | - | - | Restricted Stock Units |